Blood Lead Levels in U.S. Children Ages 1-11 Years, 1976-2016

Kathryn B Egan1, Cheryl R Cornwell1, Joseph G Courtney1

  • 1National Center for Environmental Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.

Insights

Blood lead levels (BLLs) in U.S. children have decreased by over 94% in 40 years. However, disparities persist, with higher BLLs linked to race, poverty, and housing age, indicating a need for targeted screening.

Area of Science:

  • Environmental health
  • Pediatric health
  • Public health surveillance

Background:

  • Lead exposure significantly impacts child health even at low levels.
  • Understanding blood lead level (BLL) distribution is crucial for public health interventions.
  • This study examines BLLs in U.S. children over four decades.

Purpose of the Study:

  • To describe the distribution of BLLs in U.S. children aged 1-11 years.
  • To analyze trends in BLLs over a 40-year period (1976-2016).
  • To identify sociodemographic and housing factors associated with BLLs.

Main Methods:

  • Utilized data from the National Health and Nutrition Examination Survey (NHANES) II, III, and Continuous NHANES (1976-2016).
  • Calculated geometric mean (GM) BLLs and prevalence for children aged 1-11 years.
  • Stratified analyses by age group (1-5 and 6-11 years) and sociodemographic/housing characteristics.

Main Results:

  • GM BLLs in U.S. children (ages 1-11) decreased by over 94% from 1976-1980 to 2011-2016.
  • Despite declines, an estimated 385,775 children had BLLs ≥ 5 µg/dL in 2011-2016.
  • Higher GM BLLs were associated with non-Hispanic Black race/ethnicity, lower income-to-poverty ratio, and older housing.

Conclusions:

  • Significant population-level reductions in children's BLLs have been achieved over 40 years.
  • Persistent disparities in BLLs highlight the need for targeted interventions.
  • Risk factors like race, poverty, and housing age can guide blood lead screening efforts.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
115
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
83
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
90
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
6.3K
The Periodic Table and Organismal Elements01:27

The Periodic Table and Organismal Elements

Elements are the smallest units of matter that cannot be broken down further by chemical processes. There are 118 known elements, but not all of these are naturally occurring, and only a few of them are essential for life. Living matter is composed primarily of carbon, nitrogen, hydrogen, and oxygen, with smaller amounts of other elements like calcium, phosphorus, potassium, and sulfur. Other elements are also necessary for life but only in trace amounts.
Periodic Table Provides Information...
21.4K
The Periodic Table and Organismal Elements00:57

The Periodic Table and Organismal Elements

Overview
195.2K